Open the mobile version, with barcode scanning
Class II Ongoing

Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Why: Lack of assurance of sterility.

Company
Houston Rx LLC
Houston, TX, United States
Reported
Oct 21, 2026
Recall started
Sep 25, 2026
Where sold
Nationwide in the USA.
Amount
64 vials
Full product description
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Lots / codes affected
Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.